Related Experiment Videos
Optimizing management strategies in special patient populations
1University of Toronto and University Health Network, Toronto General Hospital 9N-981, 200 Elizabeth Street, Toronto, Ontario M5G 2C4, Canada.
The American Journal of Gastroenterology
|February 2, 2006
Summary
Nucleos(t)ide analog therapy effectively suppresses chronic hepatitis B viral replication, improving liver function and survival. This treatment is crucial for managing advanced liver disease and reducing hepatocellular carcinoma risk.
Area of Science:
- Hepatology
- Virology
- Oncology
Background:
- Chronic hepatitis B infection poses significant clinical challenges, especially in patients with advanced liver disease, coinfections, or high hepatocellular carcinoma (HCC) risk.
- Management strategies require careful consideration for decompensated cirrhosis, coinfections (HCV, HIV, HDV), and HCC prevention.
Purpose of the Study:
- To review the management strategies for chronic hepatitis B infection, focusing on advanced liver disease, coinfections, and HCC risk.
- To highlight the efficacy of nucleos(t)ide analog therapy in suppressing viral replication and improving patient outcomes.
Main Methods:
- Review of current evidence and clinical practice guidelines.
- Analysis of treatment outcomes for nucleos(t)ide analogs versus interferon in specific patient populations.
- Discussion of challenges in managing coinfections and preventing HCC.
Main Results:
- Nucleos(t)ide analog therapy improves liver function, prolongs time to transplantation, and enhances survival in decompensated cirrhosis.
- Interferon is contraindicated in decompensated hepatitis B due to serious complications.
- Management of coinfections requires tailored approaches, prioritizing agents active against both viruses or the dominant pathogen.
- Effective viral suppression may reduce HCC risk; screening is recommended for high-risk individuals.
Conclusions:
- Nucleos(t)ide analogs are the cornerstone for managing chronic hepatitis B, particularly in advanced disease and coinfections.
- Strategic management is essential to improve outcomes and mitigate risks associated with hepatitis B infection and its complications.
Related Concept Videos
01:15Methods of Documentation VI: Case Management Model
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
For example, a patient with a chronic illness...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment